32863953|t|GSK-3beta activation accelerates early-stage consumption of Hippocampal Neurogenesis in senescent mice.
32863953|a|Adult hippocampal neurogenesis (AHN) deficits contribute to the progression of cognitive impairments during accelerated senescence, with the mechanistic causes poorly understood. Glycogen synthase kinase-3beta (GSK-3beta) is a critical regulator in prenatal neurodevelopment. The present study aims to study whether and how GSK-3beta regulates AHN during the accelerated senescence. Methods: AHN and AHN-dependent cognition and GSK-3beta were evaluated in 3- and 6-month senescence-accelerated mice prone 8 (SAM-P8) and senescence resistant 1 (SAM-R1) mice, respectively. GSK-3beta was selectively overexpressed in wild-type mice using adeno-associated virus, or knocked-out by crossbreeding with GSK-3beta floxed mice in the neural stem cells (NSCs) of Nestin-Cre mice, or pharmacologically inhibited with SB216763 in SAM-P8 mice. AHN was evaluated by BrdU-, DCX-staining and retrovirus-labeling. Results: AHN transiently increased at 3-month, but dramatically dropped at 6-month of age in SAM-P8 mice with a simultaneous activation of GSK-3beta at 3-month. Selective overexpression of GSK-3beta in hippocampal NSCs of wildtype mice induced long-term AHN deficits due to an accelerated depletion of NSC pool, although it transiently increased the proliferation and survival of the newborn neurons. Pharmacologically inhibiting GSK-3beta by SB216763 efficiently preserved AHN and improved contextual memory in 6-month SAM-P8 mice, while conditional knock-out of GSK-3beta in NSCs impaired AHN. Conclusion: Early-stage activation of GSK-3beta in NSCs impairs AHN by accelerating the depletion of NSC pool, and pharmacological inhibition of GSK-3beta is efficient to preserve AHN during the accelerated aging. These results reveal novel mechanisms underlying the AHN impairments during accelerated senescence and provide new targets for pro-neurogenic therapies for related diseases.
32863953	0	9	GSK-3beta	Gene	56637
32863953	60	84	Hippocampal Neurogenesis	Disease	MESH:D001750
32863953	98	102	mice	Species	10090
32863953	110	134	hippocampal neurogenesis	Disease	MESH:D001750
32863953	136	139	AHN	Disease	MESH:D001750
32863953	183	204	cognitive impairments	Disease	MESH:D003072
32863953	283	313	Glycogen synthase kinase-3beta	Gene	56637
32863953	315	324	GSK-3beta	Gene	56637
32863953	428	437	GSK-3beta	Gene	56637
32863953	448	451	AHN	Disease	MESH:D001750
32863953	496	499	AHN	Disease	MESH:D001750
32863953	504	507	AHN	Disease	MESH:D001750
32863953	532	541	GSK-3beta	Gene	56637
32863953	598	602	mice	Species	10090
32863953	656	660	mice	Species	10090
32863953	676	685	GSK-3beta	Gene	56637
32863953	729	733	mice	Species	10090
32863953	740	762	adeno-associated virus	Species	272636
32863953	801	810	GSK-3beta	Gene	56637
32863953	818	822	mice	Species	10090
32863953	858	864	Nestin	Gene	18008
32863953	869	873	mice	Species	10090
32863953	911	919	SB216763	Chemical	MESH:C417521
32863953	930	934	mice	Species	10090
32863953	936	939	AHN	Disease	MESH:D001750
32863953	964	967	DCX	Gene	13193
32863953	1011	1014	AHN	Disease	MESH:D001750
32863953	1102	1106	mice	Species	10090
32863953	1141	1150	GSK-3beta	Gene	56637
32863953	1191	1200	GSK-3beta	Gene	56637
32863953	1233	1237	mice	Species	10090
32863953	1256	1268	AHN deficits	Disease	MESH:D001750
32863953	1432	1441	GSK-3beta	Gene	56637
32863953	1445	1453	SB216763	Chemical	MESH:C417521
32863953	1476	1479	AHN	Disease	MESH:D001750
32863953	1529	1533	mice	Species	10090
32863953	1566	1575	GSK-3beta	Gene	56637
32863953	1593	1596	AHN	Disease	MESH:D001750
32863953	1636	1645	GSK-3beta	Gene	56637
32863953	1662	1665	AHN	Disease	MESH:D001750
32863953	1743	1752	GSK-3beta	Gene	56637
32863953	1778	1781	AHN	Disease	MESH:D001750
32863953	1865	1868	AHN	Disease	MESH:D001750
32863953	Association	MESH:C417521	MESH:D001750
32863953	Negative_Correlation	MESH:D001750	56637
32863953	Negative_Correlation	MESH:C417521	56637
32863953	Association	MESH:D001750	13193

